Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-08

Clinical Trial Update: Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating whether the probiotic Vivomixx can improve environmental enteropathy in pregnant women across multiple countries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vivomixx (Probiotic formulation)

Snippet

Sponsor: Tropical Gastroenterology & Nutrition Group (TROPGAN) | Conditions: Environmental Enteropathy | Phase 2 | Status: UNKNOWN